CClinicalTrials.gg
CompletedNCT05077605PULMOVISTAUpdated Jul 7, 2026

Effect of Extubation on Respiratory Function

An interventional study of Functional residual capacity measure by electrical impedance tomography in Functional Residual Capacity, sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-07.

Sponsored by Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer · Not applicable, Interventional, and Basic science

Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

The extubation phase is a risky period of anesthesia management. During this step, serious complications can arise: hypoxemia, laryngospasm, pharyngeal obstruction, pneumonia… In spite of these complications, extubation and its impact on respiratory function, particularly on the Functional Residual Capacity (FRC), remains poorly studied because of the difficulty to make bedside measurements.

The PulmoVista 500 is a clinical routine which provide effective non-invasive bedside measurements. It would be interesting to evaluate the impact of extubation on respiratory function, and more specifically FRC changes during and after extubation.

This study will allow a better physiopathological knowledge and a quality improvement patient extubation management.

Read the detailed description

The aim of this study is to evaluate the variation of functional residual capacity and its distribution before and after extubation.

Patients with scheduled surgery and receiving general anesthesia with orotracheal intubation are included and the measurements will be performed in the post-interventional monitoring room (PICU). EELI data will be collected before extubation and then at T0, then T5, T10, T15 and T20 minutes. No subsequent follow-up is required.

02

Conditions studied

  • Functional Residual Capacity

Keywords

  • Extubation
  • Functional residual capacity
  • Electrical impedance tomography
  • Pulmovista
  • Respiratory function
03

In context

Respiratory Aspiration

1,092 studies on the registry are indexed under Respiratory Aspiration; 216 are open to participants now.

This study's enrollment of 34 is below the median of 42 across 881 interventional studies indexed under Respiratory Aspiration.

Browse Respiratory Aspiration studies →

Lead sponsor

Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer is the lead sponsor of 77 studies on the registry; 20 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Patient over 18 years
  • Patient in operating room for scheduled surgery
  • Patient receiving general anaesthesia with orotracheal intubation
  • Patient given written consent after information
  • Patient covered by social security or equivalent regimen

Exclusion criteria

Exclusion Criteria:

  • Patient undergoing thoracic and spinal surgery, due to the presence of dressings that interfere with measurements,
  • Patient who has undergone intracerebral surgery because of possible communication difficulties upon awakening,
  • Patients with a body mass index (BMI) > 50 (measurements not possible)
  • Pregnant or breastfeeding patient,
  • Patient contraindicated to the use of a thoracic electroimpedancemetry technique: dressings, wounds, presence of a pacemaker, defibrillator or any other active implant.
  • Patient deprived of liberty by a judicial or administrative decision or patient subject to a legal protection measure (guardianship, curatorship...)
  • Patient in a period of exclusion from another research protocol
  • Any other reason that, in the opinion of the investigator, could interfere with the evaluation of study objectives
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Functional residual capacity

    Functional residual capacity measure during and after extubation

    Other: Functional residual capacity measure by electrical impedance tomography

Interventions

  • OtherFunctional residual capacity measure by electrical impedance tomography

    Patient functional residual capacity will be measured by electrical impedance tomography before extubation and then at 0, 10, 15 and 20 min after extubation.

06

What researchers measure

Primary outcomes

  1. End Expiratory Lung Impedance (EELI)

    EELI variation before and at different timepoints after extubation: T0, T5, T10, T15 and T20 (min).

    Time frame: Between 2 and 3 hours

Secondary outcomes

  1. Tidal volume distribution

    Percentage of tidal volume in the different regions of interest before extubation and at different timepoints after it: T0, T5, T10, T15 and T20 (min).

    Time frame: Between 2 and 3 hours

  2. Tidal volume distribution depending on patient position

    Percentage of tidal volume according to patient position: supine with or without proclivity, lateral or ventral decubitus

    Time frame: Between 2 and 3 hours

  3. Tidal volume distribution depending on surgery type and duration

    Percentage of tidal volume according to type and duration of surgery

    Time frame: Between 2 and 3 hours

  4. Tidal volume distribution depending on ventilatory mode

    Percentage of tidal volume according to the ventilatory mode: controlled ventilation, spontaneous ventilation with inspiratory assistance, spontaneous ventilation of extubated patient with or without oxygenation device

    Time frame: Between 2 and 3 hours

07

Study locations

1 site
  • Hôpital d'Instruction des Armées de Sainte Anne
    Toulon, Var 83100, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 7, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05077605
Lead sponsor
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
Responsible party
Sponsor
First posted
Oct 14, 2021
Start date
Nov 5, 2021
Primary completion
Jun 30, 2022
Completion
Jun 30, 2022
Last update
Jul 7, 2026

Study contacts

Clarisse LEGER, Nurse
study director · Hôpital d'instruction des armées Sainte-Anne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion